DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,241 filers reported holding DANAHER CORPORATION in Q2 2018. The put-call ratio across all filers is 0.63 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $6,304,000 | +22.9% | 35,650 | -3.8% | 4.01% | +5.4% |
| Q1 2020 | $5,128,000 | -15.3% | 37,047 | -6.1% | 3.81% | +12.4% |
| Q4 2019 | $6,057,000 | +2.3% | 39,467 | -3.7% | 3.39% | -0.8% |
| Q3 2019 | $5,920,000 | -10.2% | 40,987 | -11.1% | 3.42% | -4.7% |
| Q2 2019 | $6,591,000 | -10.8% | 46,120 | -17.6% | 3.58% | +6.0% |
| Q1 2019 | $7,390,000 | -6.0% | 55,980 | -26.6% | 3.38% | -9.8% |
| Q4 2018 | $7,862,000 | -35.8% | 76,245 | -32.4% | 3.75% | +3.1% |
| Q3 2018 | $12,250,000 | +2.6% | 112,735 | -6.8% | 3.64% | +3.3% |
| Q2 2018 | $11,934,000 | -34.6% | 120,935 | -35.2% | 3.52% | -2.9% |
| Q1 2018 | $18,259,000 | -7.3% | 186,485 | -12.1% | 3.63% | +8.4% |
| Q4 2017 | $19,696,000 | -6.0% | 212,195 | -13.2% | 3.35% | +10.9% |
| Q3 2017 | $20,962,000 | -18.6% | 244,375 | -19.9% | 3.02% | +0.2% |
| Q2 2017 | $25,762,000 | -3.0% | 305,275 | -1.6% | 3.01% | -3.0% |
| Q1 2017 | $26,546,000 | +5.8% | 310,375 | -3.7% | 3.11% | +4.0% |
| Q4 2016 | $25,085,000 | -1.2% | 322,268 | -0.5% | 2.99% | +1.5% |
| Q3 2016 | $25,386,000 | -11.2% | 323,848 | +14.4% | 2.94% | -10.9% |
| Q2 2016 | $28,598,000 | -3.4% | 283,148 | -9.3% | 3.30% | +2.0% |
| Q1 2016 | $29,601,000 | -7.6% | 312,048 | -9.5% | 3.24% | -0.2% |
| Q4 2015 | $32,034,000 | -20.4% | 344,900 | -26.9% | 3.24% | -2.9% |
| Q3 2015 | $40,219,000 | -12.7% | 472,000 | -12.3% | 3.34% | +5.7% |
| Q2 2015 | $46,052,000 | -18.0% | 538,050 | -18.6% | 3.16% | +0.7% |
| Q1 2015 | $56,137,000 | -35.2% | 661,215 | -34.6% | 3.14% | -22.2% |
| Q4 2014 | $86,687,000 | -7.2% | 1,011,399 | -17.7% | 4.03% | +7.3% |
| Q3 2014 | $93,383,000 | -11.6% | 1,229,046 | -8.4% | 3.75% | +4.3% |
| Q2 2014 | $105,596,000 | -6.4% | 1,341,240 | -10.9% | 3.60% | +1.0% |
| Q1 2014 | $112,859,000 | -9.1% | 1,504,787 | -6.4% | 3.56% | -4.2% |
| Q4 2013 | $124,177,000 | -0.2% | 1,608,511 | -10.4% | 3.72% | -1.8% |
| Q3 2013 | $124,390,000 | +1.7% | 1,794,430 | -7.1% | 3.79% | +2.5% |
| Q2 2013 | $122,275,000 | – | 1,931,680 | – | 3.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |